课题基金 / 基金详情

Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime

Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
批准号:
10681989
负责人:
Brian D Evavold
金额:
$71.79万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-04-01 至 2028-03-31

项目摘要

项目成果

Brian D Evavold的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Abstract Recognition of antigen is the first critical step required in triggering T cell survival, expansion, development of effector functions, and transition to memory. In a joint project between the Evavold and Williams labs, we will determine how T cell receptor (TCR) and peptide:MHC (pMHC) affinity, bond lifetimes, and force magnitude define T cell phenotype. The proposed work is therefore impactful as it begins to delineate the role each of these parameters play in the rich T cell biology associated with TCR signal strength. To date, the concept of TCR strength of signal has generally been described with three-dimensional SPR affinity in mind and measured via representative surface markers, pMHC tetramers, and functional readouts. In contrast to these methods, our studies depend on the analysis of TCR and pMHC interactions at the surface of the cell membrane using novel assays that define the in-situ two-dimensional contact that occurs between T cells and APCs during antigen recognition. The preliminary work has discovered that bond lifetime and level of force as opposed to affinity provides the major driving force for phenotypic fate. The three specific aims will redefine the concept of TCR strength of signal, dissect affinity from bond lifetime, and determine outcomes of low affinity TCRs during infection. Currently, the TCR affinity and bond lifetime for pMHC are unknown for many T cell responses, limiting our knowledge on how T cell mediated responses are triggered and how affinity and bond lifetime are translated into TCR strength of signal and effector phenotypes. Therefore, our work will prove insightful by addressing the discrepancy between affinity based predictions and actual T cell functional outcomes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defining how TCR strength of signal modulates Treg function
  • 批准号:
    10707431
  • 项目类别:
  • 资助金额:
    $60.74万
  • 财政年份:
    2022
  • 负责人:
    Brian D Evavold
  • 依托单位:
Defining how TCR strength of signal modulates Treg function
  • 批准号:
    10608466
  • 项目类别:
  • 资助金额:
    $63.27万
  • 财政年份:
    2022
  • 负责人:
    Brian D Evavold
  • 依托单位:
Biomedical Research Inclusion & Diversity to Grow Excellence in Science - Undergraduate Program in Pathology for HBCUs (BRIDGE-UP HBCU)
  • 批准号:
    10487779
  • 项目类别:
  • 资助金额:
    $32.63万
  • 财政年份:
    2022
  • 负责人:
    Brian D Evavold
  • 依托单位:
Pathogenic low affinity CD8 T cells in malaria
  • 批准号:
    10490915
  • 项目类别:
  • 资助金额:
    $65.36万
  • 财政年份:
    2021
  • 负责人:
    Brian D Evavold
  • 依托单位:
海外基金